MedTrace Logo

Management of Supraventricular Tachycardias in Children

NCT07291544 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1400

Last updated 2026-01-02

No results posted yet for this study

Summary

Background

Supraventricular tachycardias (SVTs) are the most common arrhythmic events in children, with an estimated incidence of 13 per 100,000 per year before the age of 18. Few large patient cohorts have been reported, as most published studies are single-center. Large-scale studies come from medico-administrative databases, which lack the granularity needed for detailed analysis of outcomes according to the therapies used and the type of SVT.

Furthermore, although a large proportion of neonatal SVTs do not recur (spontaneous resolution of the accessory pathway), there are limited comparative data on the effectiveness of antiarrhythmic therapies specifically in children after the age of 1 year. Management therefore varies greatly, in part because current guidelines propose different therapeutic options based on low-level evidence.

Objectives:

* Describe the management of SVTs (antiarrhythmic therapies and catheter ablation) in children in France
* Compare the effectiveness of different antiarrhythmic treatments according to age (\<1 year and \>1 year) and type of SVT
* Analyze the incidence of adverse events and complications associated with antiarrhythmic treatments and catheter ablation

Conditions

  • Supraventricular Arrhythmias
  • Children
  • Management

Interventions

OTHER

Management of children with supraventricular tachycardias

Observational analysis of the management of supraventricular tachycardias (antiarrhythmic drugs and catheter ablations)

Sponsors & Collaborators

  • Paris Cardiovascular Research Center (Inserm U970)

    lead OTHER_GOV

Eligibility

Min Age
0 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2000-01-01
Primary Completion
2025-09-30
Completion
2025-09-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07291544 on ClinicalTrials.gov